Ignite Creation Date:
2024-05-06 @ 1:20 PM
Last Modification Date:
2024-10-26 @ 1:12 PM
Study NCT ID:
NCT03991403
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-03
First Post:
2019-06-05
Brief Title:
Study of Atezolizumab Combination Carboplatin Paclitaxel Bevacizumab in EGRF Mutation or ALK Translocation NSCLC
Sponsor:
Organization:
Samsung Medical Center